首页> 美国卫生研究院文献>Iranian Journal of Basic Medical Sciences >MiR-9-5p and miR-106a-5p dysregulated in CD4+ T-cells of multiple sclerosis patients and targeted essential factors of T helper17/regulatory T-cells differentiation
【2h】

MiR-9-5p and miR-106a-5p dysregulated in CD4+ T-cells of multiple sclerosis patients and targeted essential factors of T helper17/regulatory T-cells differentiation

机译:多发性硬化症患者CD4 + T细胞中MiR-9-5p和miR-106a-5p失调以及T辅助细胞/调节性T细胞分化的靶向必需因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective(s):Multiple sclerosis (MS) is considered as a chronic type of an inflammatory disease characterized by loss of myelin of CNS. Recent evidence indicates that Interleukin 17 (IL-17)-producing T helper cells (Th17 cells) population are increased and regulatory T cells (Treg cells) are decreased in MS. Despite extensive research in understanding the mechanism of Th17 and Treg differentiation, the role of microRNAs in MS is not completely understood. Thereby, as a step closer, we analyzed the expression profile of miR-9-5p and miR-106a-5p, and protein level of retinoic acid receptor (RAR)-related orphan receptor C (RORC; Th17 master transcription factor) as direct target of miR-106a-5p and forkhead box P3 (FOXP3; Treg master transcription factor) as indirect target of miR-9-5p in CD4+ T cells in two groups of relapsing and remitting in our relapsing-remitting MS (RR-MS) patients.
机译:目的:多发性硬化症(MS)被认为是一种慢性疾病,以中枢神经系统髓磷脂的丧失为特征。最近的证据表明,MS中产生白介素17(IL-17)的T辅助细胞(Th17细胞)的数量增加而调节性T细胞(Treg细胞)的数量减少。尽管在了解Th17和Treg分化的机制方面进行了大量研究,但尚未完全了解microRNA在MS中的作用。因此,作为更近一步,我们分析了miR-9-5p和miR-106a-5p的表达谱以及视黄酸受体(RAR)相关的孤儿受体C(RORC; Th17主转录因子)的蛋白水平是否直接miR-106a-5p和叉头盒P3(FOXP3; Treg主转录因子)的靶标作为CD4 + T细胞中miR-9-5p的间接靶标在两组复发和缓解中缓解型MS(RR-MS)患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号